Femasys (FEMY) Free Cash Flow Growth (3y) (2023 - 2026)
Femasys (FEMY) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.84 Bn | 121.63 Bn | 1.96 Bn | 30.99% |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn | 414.89% |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | 43.37% |
| 4 | Medline | 32.82 Bn | 30.58 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 27.06% |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.97 Bn | 329.20 Mn | -4.85% |
| 7 | Solventum | 14.09 Bn | 13.53 Bn | 1.10 Bn | -37.77% |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | 23.97% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -3.97% |
| 10 | Femasys | 14.28 Mn | 8.89 Mn | - | -16.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.71% |
| Dec 31, 2025 | -13.45% |
| Sep 30, 2025 | -26.63% |
| Jun 30, 2025 | -20.30% |
| Mar 31, 2025 | -19.15% |
| Dec 31, 2024 | -29.85% |
| Sep 30, 2024 | -43.83% |
| Jun 30, 2024 | -18.16% |
| Mar 31, 2024 | -58.63% |
| Dec 31, 2023 | -34.33% |
| Sep 30, 2023 | -49.53% |